Idera Pharmaceuticals Related Correlations

IDRADelisted Stock  USD 0.43  0.05  10.42%   
Generate correlation matrix for Idera Pharmaceuticals and other related equities to check the degree to which Idera Pharmaceuticals price movement is correlated to its related entities. Use comma (,) to separate each symbol. If not specified, the peers will be provided automatically based on Macroaxis sector classification standards for Idera Pharmaceuticals. To filter out specific equities, please toggle its corresponding legend item. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Specify up to 10 symbols:
Please note, there is a significant difference between Idera Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Idera Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Idera Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Correlations

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
CDWGMS
EYESTKL
TBBBGMS
CDWTBBB
CDWSTKL
SHOOVSCO
  
High negative correlations   
MYTEVSCO
VSCOGMS
VSCOTBBB
VSCOSTKL
SHOOMYTE
VSCOCDW

Risk-Adjusted Indicators

There is a big difference between Idera Stock performing well and Idera Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Idera Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.